Position in ENTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,389,038
-$1,751,847 QoQ
Shares Held
643,967
-27.0% QoQ
Ownership
2.21%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Derivatives in ENTA
reported options exposure · as of Sep 30, 2025CallValue
$2,279,088
CallShares
190,400
PutValue
$198,702
PutShares
16,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. ENTA ranks #117 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ENTA
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,389,038 | 643,967 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,140,885 | 882,097 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,572,649 | 670,428 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,348,565 | 948,084 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $2,279,088 | 190,400 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $198,702 | 16,600 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $378,000 | 50,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $11,026,963 | 1,458,593 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,435,064 | 1,346,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,157,675 | 896,987 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,576,216 | 731,295 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,860,364 | 683,143 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,331,090 | 706,248 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,199,976 | 765,141 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,428,283 | 1,023,123 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,996,621 | 233,487 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,693,264 | 140,783 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,608,981 | 56,083 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,949,482 | 37,584 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,084,184 | 22,936 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,678,874 | 65,733 | Shares | Sole | 2022-05-16 | |
| 2022-03-31 | $711,800 | 10,000 | Put | Sole | 2022-05-16 | |
| 2021-12-31 | $1,183,916 | 15,832 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $880,611 | 15,501 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,194,055 | 140,742 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,176,035 | 23,845 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,441,974 | 176,769 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,764,297 | 125,913 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,852,096 | 36,887 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,123,811 | 80,183 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||